Gene · 9252
Papers1,701
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,701
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers. | Front Genet | 2023 | 36741322 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| MAPK Cascade Signaling Is Involved in α-MMC Induced Growth Inhibition of Multiple Myeloma MM.1S Cells via G2 Arrest and Mitochondrial-Pathway-Dependent Apoptosis In Vitro. | Pharmaceuticals (Basel) | 2023 | 36678620 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 36674820 | PubTator, text mining | PubMed |
| Higher Oxidative Stress in Endometriotic Lesions Upregulates Senescence-Associated p16ink4a and β-Galactosidase in Stromal Cells. | Int J Mol Sci | 2023 | 36674426 | PubTator, text mining | PubMed |
| Early response evaluation by single cell signaling profiling in acute myeloid leukemia. | Nat Commun | 2023 | 36611026 | PubTator, text mining | PubMed |
| The genomic regulation of metastatic dormancy. | Cancer Metastasis Rev | 2023 | 36600151 | PubTator, text mining | PubMed |
| Therapeutic potential of low dose ionizing radiation against cancer, dementia, and diabetes: evidences from epidemiological, clinical, and preclinical studies. | Mol Biol Rep | 2023 | 36595119 | PubTator, text mining | PubMed |
| Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status. | Cell Rep Med | 2023 | 36584682 | PubTator, text mining | PubMed |
| CK2 promotes jasmonic acid signaling response by phosphorylating MYC2 in Arabidopsis. | Nucleic Acids Res | 2023 | 36546827 | PubTator, text mining | PubMed |
| Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. | Antiviral Res | 2023 | 36423831 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease. | Mol Cell Proteomics | 2023 | 36423813 | PubTator, text mining | PubMed |
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
| Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices. | Mol Divers | 2023 | 36057867 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| Brain mineralocorticoid and glucocorticoid receptor balance in neuroendocrine regulation and stress-related psychiatric etiopathologies. | Curr Opin Endocr Metab Res | 2022 | 38037568 | PubTator, text mining | PubMed |
| Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing. | Front Immunol | 2022 | 36713456 | PubTator, text mining | PubMed |
| SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF. | Cell Biosci | 2022 | 36585710 | PubTator, text mining | PubMed |
| Epigenetic mechanisms in metal carcinogenesis. | Toxicol Rep | 2022 | 36561948 | PubTator, text mining | PubMed |
| Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia. | Front Pharmacol | 2022 | 36561342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9252/papers?page=8